Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-156
Closed -$71 3662
2025
Q2
$71 Hold
156
﹤0.01% 3203
2025
Q1
$63 Hold
156
﹤0.01% 2973
2024
Q4
$103 Hold
156
﹤0.01% 2595
2024
Q3
$132 Hold
156
﹤0.01% 2480
2024
Q2
$104 Hold
156
﹤0.01% 2237
2024
Q1
$203 Hold
156
﹤0.01% 1635
2023
Q4
$89 Hold
156
﹤0.01% 1723
2023
Q3
$118 Hold
156
﹤0.01% 1654
2023
Q2
$114 Hold
156
﹤0.01% 1516
2023
Q1
$118 Hold
156
﹤0.01% 1492
2022
Q4
$150 Hold
156
﹤0.01% 1442
2022
Q3
$0 Hold
156
﹤0.01% 1411
2022
Q2
$1K Hold
156
﹤0.01% 1159
2022
Q1
$1K Hold
156
﹤0.01% 1009
2021
Q4
$1K Hold
156
﹤0.01% 1049
2021
Q3
$1K Hold
156
﹤0.01% 857
2021
Q2
$1K Buy
156
+30
+24% +$209 ﹤0.01% 796
2021
Q1
$1K Hold
126
﹤0.01% 809
2020
Q4
$1K Hold
126
﹤0.01% 733
2020
Q3
$1K Buy
+126
New +$1.12K ﹤0.01% 698

Other funds holding VXRT

Larson Financial Group's VXRT Position: Q3 2025 in Review

Larson Financial Group sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 156 shares — an estimated $71 sold.

Larson Financial Group first reported a position in VXRT in Q3 2020 and held it in 20 quarters. The position peaked at $1K in Q2 2022. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • Larson Financial Group reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • Larson Financial Group sold 156 Vaxart shares in Q3 2025, an estimated $71.
  • Larson Financial Group first reported a position in Vaxart in Q3 2020 and held it in 20 quarters.
  • Larson Financial Group's Vaxart position peaked at $1K in Q2 2022.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Larson Financial Group's 13F filing for Q3 2025, filed 14 Nov 2025.